Apple Style Slider
โ† Back
AUROPHARMA
Pharma
Failure
VRZ Low Intraday Oct 08, 2026
๐Ÿ’Š How Did AUROPHARMA BOF Fail? | Failed VRZ Low Reclaim | Intraday Analysis ๐Ÿ”ฌ

๐Ÿ’Š How Did AUROPHARMA BOF Fail? | Failed VRZ Low Reclaim | Intraday Analysis ๐Ÿ”ฌ


๐Ÿงพ Trade Setup Snapshot

๐Ÿ’Š Stock: AUROBINDO PHARMA LTD

๐Ÿฅ Sector: Pharmaceuticals

๐Ÿ“Š Trade Type: Intraday

โฑ๏ธ Chart Time Frame: 5 Minutes

๐Ÿงญ VRZ Marking Time Frame: 30 Minutes

๐Ÿ“ Key Level: VRZ Low โ€“ โ‚น1,668.50

๐Ÿงฉ Setup Type: Bullish Breakout Failure (BOF)

๐Ÿ“ˆ Expected Direction: Bullish reversal after breakdown and reclaim


BOF Scanner App identified this setup at 10:10 am




๐Ÿ“ก Overall Market Scenario

๐Ÿ“‰ AUROPHARMA opened under noticeable selling pressure and gradually moved toward the โ‚น1,668.50 VRZ Low. โš ๏ธ After breaking below the key level, the expected bullish reversal failed to gain traction. ๐Ÿ”ป Price remained beneath the VRZ Low and continued to develop a weak intraday structure.


๐Ÿงฉ Technical Setup Analysis

๐Ÿ”Ž Following the breakdown, price consistently traded below โ‚น1,668.50 and formed a sequence of lower highs and lower lows. ๐Ÿงฑ Recovery attempts remained weak, with buyers unable to push price back above the key reversal zone. ๐Ÿ“‰ The sustained trading below the VRZ Low kept sellers in control.


โšก Failed Reversal Attempt

๐ŸŽฏ The bullish BOF required a decisive reclaim of โ‚น1,668.50 followed by sustained acceptance above the zone. ๐Ÿšซ Instead, price repeatedly failed to recover the broken level. ๐Ÿ”ด With no convincing reclaim or bullish follow-through, the expected reversal setup gradually lost validity.


๐Ÿ“Š Price Action & Momentum Review

๐ŸŸฅ Bearish candles dominated the major downside phases of the session. ๐ŸŸข Although occasional green candles appeared during intraday consolidation, they failed to create meaningful upside momentum. ๐Ÿ“Š The inability of buyers to sustain recovery kept the broader price action bearish.


๐Ÿงญ Confirmation of Bearish Failure

  • ๐Ÿ“‰ Price broke below the โ‚น1,668.50 VRZ Low.
  • ๐Ÿšซ The broken level was never decisively reclaimed.
  • ๐Ÿ”ป Recovery attempts remained below the VRZ zone.
  • ๐Ÿงฑ Lower highs continued to develop.
  • โš ๏ธ Buyers failed to establish acceptance above โ‚น1,668.50.
  • ๐Ÿ“Š Bearish structure remained intact throughout the session.
  • ๐Ÿ”ป Price eventually moved toward โ‚น1,645.00.


๐Ÿ“‹ Trade Management Evaluation

๐ŸŽฏ The bullish BOF required reclaim + acceptance + bullish follow-through above โ‚น1,668.50. ๐Ÿšซ Since these conditions did not materialize, the setup lacked sufficient confirmation for a sustained bullish entry. ๐Ÿงญ Waiting for a genuine reclaim would have provided stronger trade validation and reduced exposure to the continuing downside move.


๐Ÿ’ฐ Managing Risk During BOF Failure

๐Ÿ” When a BOF setup fails to reclaim its reference zone, the original reversal thesis should be reassessed quickly. โš ๏ธ Holding onto a bullish bias while price remains below the VRZ Low can increase downside risk. ๐Ÿงฏ Respecting the invalidation level helps protect capital when the anticipated reversal does not develop.


๐Ÿ”Ž Emotional Discipline Assessment

๐Ÿ‘€ A breakdown near a VRZ level can create an expectation that price will soon reverse. โš ๏ธ However, a potential reversal is not confirmed until buyers demonstrate actual strength. ๐Ÿง  AUROPHARMA highlights why traders should avoid anticipating the reclaim and instead wait for clear evidence that the broken level has turned back into support.


๐ŸŽ“ What Traders Can Learn

๐Ÿ“ โ‚น1,668.50 remained the critical decision level for this setup. ๐Ÿ”ป Price failed to reclaim the VRZ Low and instead continued to trade below it for most of the session. ๐ŸŽฏ The setup reinforces the importance of waiting for rejection, reclaim and sustained acceptance before validating a bullish BOF reversal.


๐Ÿงพ Complete Trade Performance

โ›” The AUROPHARMA bullish BOF setup failed because price could not reclaim and sustain above the โ‚น1,668.50 VRZ Low. ๐Ÿป Sellers maintained control below the zone, while buyers failed to generate meaningful recovery momentum. ๐Ÿ“‰ Price eventually declined toward โ‚น1,645.00, confirming continued bearish pressure and invalidating the bullish reversal thesis.

Download BOF Scanner App